CPD Accredited
17th International Conference on Chemistry and Medicinal Chemistry

Dubai, UAE

December 4-6, 2023

Dr. Federica Pellati graduated cum laude in 2000 in Pharmaceutical Chemistry and Technology at the Faculty of Pharmacy of the University of Modena and Reggio Emilia. In 2004 she got a PhD degree in Pharmaceutical Sciences. Then she had a post-doctoral fellowship position in Medicinal Chemistry and in 2006 she got a position of Assistant Professor in Medicinal Chemistry at the University of Modena and Reggio Emilia. In 2014, she got the Italian Professorship Qualification (ASN 2012) as an Associate Professor in Medicinal Chemistry. The research activity of Dr. Pellati is focused on the development of innovative techniques for the extraction and analysis of bioactive natural products, and on the isolation of new bioactive compounds of natural origin. She has a number of national and international research collaborations and she participates to peer-reviewed research projects. Dr. Pellati is the author of more than 60 papers in ISI indexed international journals, n. 3 book chapters, n. 4 proceedings in international journals, n. 2 patents and more than 90 congress communications (oral and poster).

Chiara Milanese is associate professor of Physical Chemistry at the Chemistry Department of the University of Pavia (Italy). Her main research interests regard the synthesis of innovative nanomaterials for solid state hydrogen storage and for energy storage, their physico-chemical characterization and the evaluation of their storage performance. In the last 5 years, her attention was mainly focused on C-based materials, in particular fullerene derivatives and biochar. She is author of 165 papers on materials science topics and she is expert of the IEA Task 40 “Energy storage and conversion based on hydrogen”.

Andrés E. Dulcey was born in Cali, Colombia. After completing a Bachelor of Science in Chemistry from The Ohio State University, he joined the laboratory of Professor Virgil Percec at the University of Pennsylvania. His doctoral research focused on the design, synthesis and structural characterization of biologically-inspired libraries of amphiphilic compounds which self-assemble into functional, helical, porous channels. After completion of his doctoral degree, Andrés joined the National Institutes of Health (NIH), first as a Postdoctoral Fellow and then as a Research Scientist, where he has spent over 10 years working in different modalities of medicinal chemistry. Currently, Andrés is at the National Center for Advancing Translational Sciences at the NIH, where he works as a Research Scientist at the forefront of translation, advancing programs in target identification and validation, assay development and screening, probe development and lead optimization, and drug repurposing, with the goal of furthering the understanding of biochemical pathways and aiding the development of new medicines.

Laura Chronopoulou has completed her PhD in Materials Science at the University of Rome La Sapienza. She is currently working as a post-doc Researcher at the Department of Chemistry of the University of Rome La Sapienza, in the Industrial Chemistry group. She is a member of the Nanobiotechnology lab run by Prof. Cleofe Palocci. Her main research interests are the following: Synthesis and characterization of biopolymeric nanoparticles for drug delivery applications; Bioproduction of peptidic hydrogels for biotechnological applications; Structure-activity studies of lipolytic enzymes immobilized on nanocarriers; Microfuidic approaches to the synthesis of nanomaterials. She has authored 40 publications that have been cited over 600 times, and her publication H-index is 15.

Julietta V. Rau (Dr, PhD) is currently researcher, head of the laboratory and research group at the Institute of the Structure of Matter of the Italian National Research Council (ISM-CNR, Rome, Italy). She is the author of more than 120 publications in International Journals and about 145 psentations and Invited talks at International Conferences. She received several international awards for her research achievements. Her psent H-index is 24.

Luis A. Vargas received his MS at the Catholic University, Chile and his PhD in 1963 from the University of Madrid, Spain under Dr. Rafael Perez-Ossorio. He was Professor and Chair of the Chemistry Dept. at the Catholic University, Chile until 1968. He completed Post-Doctoral work in 1971 at New York University under Dr. Y.E. Rhodes. He was senior research scientist at Long Island Jewish Medical Center and has also been a Professor at Queensborough Community College in NY since 1992.

Henry M. Sobell completed his studies at Brooklyn Technical High School (1948-1952), Columbia College (1952-1956), and the University of Virginia School of Medicine (1956-1960). Instead of practicing clinical medicine, he then went to the Massachusetts Institute of Technology (MIT) to join Professor Alexander Rich in the Department of Biology (1960-1965), where, as a Helen Hay Whitney Postdoctoral Fellow, he learned the technique of single crystal X-ray analysis. He then joined the Chemistry Department at the University of Rochester, having been subsequently jointly appointed to both the Chemistry and Molecular Biophysics departments (the latter at the University of Rochester School of Medicine and Dentistry), becoming a full tenured Professor in both departments (1965-1993). He is now retired and living in the Adirondacks in New York, USA

György Keglevich graduated from the Technical University of Budapest in 1981 as a chemical engineer. He got “Doctor of Chemical Science” degree in 1994, in the subject of organophosphorus-chemistry. He has been the Head of the Department of Organic Chemistry and Technology since 1999. Within organophosphorus chemistry, his major field embraces a P-heterocycles involving selective syntheses, as well as bioactive and industrial aspects. He also deals with environmentally friendly chemistry involving MW chemistry, its theoretical aspects, phase transfer catalysis, the development of new chiral catalysts, and the use of ionic liquids. He is the author or co-author of ca. 550 papers (the majority of which appeared in international journals) including ca. 70 review articles and 40 book chapters. He is, among others, the member of the Editorial Board of Molecules, Heteroatom Chemistry and Phosphorus, Sulfur and Silicon, and the Related Elements, and Current Microwave Chemistry. He is the Editor-in-Chief for Current Organic Chemistry and Current Green Chemistry, the co-Editor-in-Chief for Current Catalysis, Associate Editor for Current Organic Synthesis and Letters in Drug Design and Discovery, and Regional Editor for Letters in Organic Chemistry.

Bölcskei H has completed her MSc study as a chemical engineer from University of Technology, Budapest, Hungary. She received her PhD in 1979 at the same university, and her scientific degree “candidate of sciences” in 1988 from the Hungarian Academy of Sciences. Between 1973-2013 she worked as a researcher at the Hungarian pharmaceutical company Gedeon Richter Plc. Since 2009 she has been working as the associate professor of University of Technology and Economics, Budapest, Hungary. Her main research interest: alkaloid chemistry, organic chemistry, medicinal chemistry. She has over 60 publications that have been cited over 200 times.

Feng Wang (PhD Theoretical/Computational Chemistry, Spectroscopy) is Professor of Chemistry and Deputy Chair of Department of Chemistry and Biotechnology at Swinburne University of Technology, Australia. Feng received her PhD degree at the University of Newcastle (Australia, 1994), worked at the University of Waterloo (1994-1996) as an NSERC Canada International Postdoctoral Fellow and Research Fellow at School of Chemistry, The University of Melbourne (1996-2000). After a short period at a supercomputer centre, she joined Swinburne University of Technology in 2003. Feng has led many theoretical/computational chemistry driven discoveries in a broad spectrum of applications in medicinal, biological, solar energy etc in chemistry and physics and has published over 150 peer reviewed journal articles. Feng is Honorary Professor at School of Chemistry, University of Melbourne, Fellow of RACI and Fellow of the AIP. She also serves on national scientific research committees such as the National Computational Merit Allocation Committee (NCMAC, Australia) and has been an expert panel member for National Research Councils including Ireland, Czech Republic, Portugal, Romania and Canada (Quebec) etc.

Christophe Len received his Ph.D. from the University of Picardie-Jules Verne (UPJV) in Amiens (France) under the supervision of Professor P. Villa in the field of carbohydrate chemistry. In 1996, he joined Doctor G. Mackenzie's group at the University of Hull (UK) as a post-doctoral fellow to work on the synthesis of nucleoside analogues. In 1997, CL became Assistant Professor at the Laboratoire des Glucides of UPJV and worked on the chemistry of antiviral nucleoside analogues specialising on those with novel glycone systems. In 2003, CL received his habilitation and was promoted to full Professor in 2004 at the University of Poitiers (France) where he was the supervisor of the team "Biomolecules: Synthesis and Molecular Organization". For 2008, CL had a secondment to the University of Technology of Compiègne - UTC (France) where he created a new scientific team called "Organic Chemistry and Alternative Technologies" with the perspective to develop research activity on green chemistry and sustainable development. In 2010, CL became full Professor at the University of Compiègne - UTC (France). Since November 2017, CL has developed his research at Chimie ParisTech (France) in the group "Catalysis, Synhesis of Biomolecules and Sustainable Development" diriged by Dr Virginie Vidal.

Vladimer Tsitsishvili, Dr. Physical Chemistry, has his expertise in various fields of Physical Chemistry and Chemical Technologies. He has developed a new concept, a model of a heterodynamic system for describing relaxation, diffusion and other phenomena in dynamically in homogeneous media. More recently, he has developed new methodologies for preparation and modification of zeolite molecular sieves, adsorbents, ion exchangers, and catalysts. He is author of over 450 papers, 2 books on Physical Chemistry and owner of several patents. He is the Member of the Georgian National Academy of Sciences. He was the recipient of several Awards, including the Georgian Order of Honour (2013) and Prizes of the Georgian National Academy of Sciences (2005, 2018).

Lingxue Kong was awarded his PhD from the University of New South Wale in Australia in 1997. One of his research interests lies on the development of nanomaterials for colorectal cancers by incorporating targeting reagents to improve the efficacy of drugs. He has published more than 245 scientific articles in leading international journals with a citation of more than 5500 and a h-indexof 41.

Professor of Biochemistry at Uppsala University in Sweden and a specialist in enzymology and biosensor-based drug discovery. Helena Danielson has applied biophysical methods for enzymology and drug discovery. Her current focus is on discovery of leads targeting epigenetic enzymes and establishing a fundamental understanding the dynamics of molecular interactions. She has extensive experience of the commercial drug discovery process through 30 years of collaborative research with partners in pharmaceutical and biotechnological industry. An important collaboration with Biacore AB was initiated in 1997 and has resulted in adapting biosensor technology for drug discovery and the development of new biosensor products for the drug discovery industry. Academic career: Master of Science in Chemical Engineering at Lund University (1982), Fulbright scholarship (1982-84) and Master of Science in Biochemistry (1984) at the University of Rochester, Rochester, NY, USA. Ph.D. in Biochemistry at Stockholm University (1987). Researcher at Karolinska Institutet in Stockholm (1987-88). At Uppsala University since 1988. Professor of Biochemistry from 2002. Co-founder of Beactica AB (2006), Chief Scientific Officer until 2014. Board member and scientific advisor.

Dr. Shaodong Guo is Associate Professor in the Department of Nutrition and Food Science at Texas A&M University College. He received his Ph.D in Physiology from Peking University, China. Then he completed his postdoctoral research training in Genetics, Biochemistry, and Medicine in the Chinese Academy of Sciences, the University of Illinois at Chicago, and Harvard University, respectively. Dr. Guo was Instructor in Medicine at Children's Hospital Boston and Harvard Medical School for two years prior to joining the faculty at Texas A&M Health Science Center. Currently, Dr. Guo serves as senior editor for the Journal of Endocrinology and Journal of Molecular Endocrinology, two major official journals of Endocrine Society of Europe, UK, and Australia, and he is the textbook chapter writer for Metabolic Syndrome edited by Rexford Ahima and published by Springer in 2016. Dr. Guo lab research focuses on insulin/glucagon and estrogen signal transduction, insulin resistance, gene transcriptional control of nutrient homeostasis, and cardiac dysfunction in diabetes. Dr. Guo has been working on the gene transcriptional regulation of metabolic homeostasis by insulin receptor substrate proteins (IRS) and Forkhead FoxO transcription factors and he has been funded by American Diabetes Association (ADA), American Heart Association, and the National Institute of Health of USA. He is a recipient of ADA junior faculty award, career development award, and Richard R. Lee Award. His work has been published in a number of journals including the JBC, Endocrinology, Hypertension, Diabetes, Circulation Research, AJP, MCB, and Nature Medicine, receiving more than 5,500 citations from the Google Scholar.

Dr. Farooq Sher is a Lecturer in the School of Mechanical, Aerospace and Automotive Engineering at Coventry University. His undergraduate degree was in Chemical Engineering, followed by MSc Chemical Engineering from the University of Leeds UK. He was awarded PhD in Chemical Engineering from the University of Nottingham UK. His PhD research was on the development of oxy-fuel combustion technology for carbon capture and storage (CCS). After that, he worked as a Research Fellow and Lecturer at the University of Nottingham. Dr. Sher has been involved in commissioning and operation of a fluidised bed combustor, a UK Engineering and Physical Research Council funded project (EPSRC, grant no. EP/ EP/M01536X/1), the overall budget of the project was £1 million. The project explored the utilisation of various fuels as a source of renewable energy in addition with particular emphasis on CO2, NOx, and SOx emission control in partnership with major UK power generation companies. Dr. Sher has published several research papers, book chapters and editorials apart from this he is the editor of different international scientific journals. He has reviewed hundreds of research papers for several high impact journals. Dr. Sher has been awarded a top reviewer for Engineering in 2018 and 2019 from Publons Academy. Dr. Sher is a member of departmental and faculty committees. Externally, he is an associate member of Institute of Chemical Engineers (IChemE), senior member of the American Institute of Chemical Engineers (AIChE) and professional engineer member of Engineers Australia (IEAust). Dr. Sher is also interested in various forms of community work both within the University and outside such as British Red Cross, where he is a refugee support worker, a school governor and as a STEM Ambassador for youngsters to value them in their lives and careers.

Al-Tel received his MS in Natural Product Chemistry in 1990 from the Department of Chemistry, Jordan University and Pennsylvania State University, and PhD in 1995 from Tuebingen University-Germany followed by an NIH Postdoctoral Fellowship under the supervision of Professor Scott Sieburth, at State University of New York, Stony Brook, NY.

Mr. De la Parra-Solomon is an entrepreneur focused on Information Technology, Education and Health. He is creative, results-driven and has 16+ years of Digital Strategy experience in architecture and implementation. Mr. De la Parra-Solomon is the Chief Strategy Officer and Co-Founder of the Quantum Brain Research Institute (www.quantumbrain.institute), a HealthTech initiative established in Tallinn, Estonia focused on Mental Health and Information Technology solutions. He serves as CEO and Co-founding Partner at The Solomon Brokerage Firm (www.solomonbrokerage.com). He also is the former Vice President of Digital Strategy at Mass Media Division, while also being the CEO of De la Parra Mobile Solutions. He is the former Vice President of Strategy and Operations PetroM Corp and its subdivision PetroM Logistics and PetroM Pharma, the former COO & Co-founder at RegenerAge Clinic & RegenerAge Beauty. Mr. De la Parra-Solomon is the former CEO & Founder at Astrum Salud Móvil and its Telemedicine service Astrum Móvil, former Digital Strategy Director & Co-founder at Dr. Jois, BiorganicAging, What Skin Needs/WSN International Pty. Ltd. He also served as a member of the Board of Advisors and is former Chief Marketing Officer at ReAnima Advanced Biosciences and served as Digital Media Director at Bioquark, Inc. He also served as the Latin America Region Manager and Digital Strategy adviser at CardiacSense and is former CITO & Senior Partner at Cerezo Editores. Within the academic and educational fields, Mr. De la Parra-Solomon acted as the Executive Vice President: Executive Chairman of the WAMS Mobile Health Division, WAMS Chief Coordinating Officer, as a former member of the WAMS Executive Council (WAMS Executive Board), a former member of the WAMS Education & Training Board (ETB), a former member of the WAMS Editorial Board, an Honorary Member of the Academy Faculty FWAMS, an Honorary Fellow of the Academy & was also a Senior Partner at WAMS, The World Academy of Medical Sciences. He was also an Advisory Board member, functioned as the Chief Operating Officer and was a Co-founding Partner at The Reprogramming Medicine Association. Mr. De la Parra-Solomon is also a member of Singularity University and of OpenExo. In relation to the organizations that Mr. De la Parra has collaborated with for social impact and empowerment, he is a member of the Laurentia Project and of Cerebro Mexico, he serves as an Advisory Board member of the Lifeboat Foundation, as an Advisory Board member of the Future Worlds Center – Cyprus Neuroscience & Technology Institute (Senior TV Program), while also being a Federated Member of the International Longevity Alliance and a member of the Transhumanist Party. He is a voting citizen and is running for Mayor & future Parliamentary Candidate at Asgardia. He served as the Chief Digital Strategy Officer and is Member of the Board of Advisors and an Honorary Member at the Transdisciplinary Agora for Future Discussions, a member of the Web Committee at the Life Extension Advocacy Foundation/Lifespan.io, volunteered with SENS Research Foundation for the OncoSENS Program in Digital Strategy, and acted as Digital Strategy adviser at the Major Mouse Testing Program. He also functioned as the founder and former Board of Directors member of Astrum Fundación and was Digital Strategy Advisor for POKI Ciudad Orgánica. He is also a part of the General Member Board at the National Autism Association, the National Fibromyalgia Association, the International Literacy Association, and the United Spinal Association.